Yunnan Bethany Biotechnology Group News and Activities

Yunnan Bethany Biotechnology Group is one of the...

• CSI 500;
• TOB Iconic 10,000.

Yunnan Bethany Biotechnology Group is a company listed under the stock ticker 300957 (CN).

View the org chart displaying its 9 main executives

Most searched biographies at Yunnan Bethany Biotechnology Group

• Wei Zhou, Director
• Kui Zhou, Director
• Feifei Wang, Director

Create your alert
to follow the executive moves at Yunnan Bethany Biotechnology Group.

Yunnan Bethany Biotechnology Group has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Yunnan Bethany Biotechnology Group

Social media about Yunnan Bethany Biotechnology Group

• Yunnan Bethany Biotechnology Group on Wikipedia, Google News & Yahoo Finance
• Yunnan Bethany Biotechnology Group on LinkedIn, X (Twitter) & YouTube